Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer
NCT04142892
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Onapristone
Sponsor
SOLTI Breast Cancer Research Group